Last reviewed · How we verify
Randomization between two referenced treatments — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Randomization between two referenced treatments (Randomization between two referenced treatments) — University Hospital, Clermont-Ferrand.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Randomization between two referenced treatments TARGET | Randomization between two referenced treatments | University Hospital, Clermont-Ferrand | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Randomization between two referenced treatments CI watch — RSS
- Randomization between two referenced treatments CI watch — Atom
- Randomization between two referenced treatments CI watch — JSON
- Randomization between two referenced treatments alone — RSS
Cite this brief
Drug Landscape (2026). Randomization between two referenced treatments — Competitive Intelligence Brief. https://druglandscape.com/ci/randomization-between-two-referenced-treatments. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing